CGEM: Cullinan Therapeutics, Inc. Stock

by  •  • Comments Off on CGEM: Cullinan Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 438.85
Enterprise Value ($M) 355.84
Book Value ($M) 590.33
Book Value / Share 10.09
Price / Book 0.74
NCAV ($M) 383.17
NCAV / Share 6.55
Price / NCAV 1.15

Profitability (mra)
Return on Invested Capital (ROIC) -0.28
Return on Assets (ROA) -0.37
Return on Equity (ROE) -0.39

Liquidity (mrq)
Quick Ratio 13.53
Current Ratio 13.53

Balance Sheet (mrq) ($M)
Current Assets 414.67
Assets 621.82
Liabilities 31.50
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -196.92
Net Income -167.38

Cash Flow Statement (mra) ($M)
Cash From Operations -145.30
Cash from Investing -136.31
Cash from Financing 266.19

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Biotechnology Value Fund L P 9.99 31.94
11-14 13G/A Blue Owl Capital Holdings LP 3.45 -41.20
11-12 13G/A Vanguard Group Inc 5.17 0.00
11-08 13G BlackRock, Inc. 7.50 0.00
10-31 13G/A Franklin Resources Inc 3.80 -33.22
04-24 13G Flynn James E 5.71

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-02 87,226 328,966 26.52
2025-04-01 151,828 525,137 28.91
2025-03-31 157,569 434,590 36.26
2025-03-28 47,112 191,339 24.62

(click for more detail)

Similar Companies
CABA – Cabaletta Bio, Inc. CCCC – C4 Therapeutics, Inc.
CGC – Canopy Growth Corporation CGON – CG Oncology, Inc.
COGT – Cogent Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io